Daunorubicin hydrochloride, Anthracycline antibiotic

Be the first to review this product! Submit a review

|

(0 Publication)

MW 564 Da, Purity >95%. Anthracycline antibiotic. DNA and RNA synthesis inhibitor. Reduces tau mRNA levels. Induces DNA fragmentation and apoptosis. Antiproliferative and cytotoxic effects in vivo. Orally active.

View Alternative Names

14 3 3 gamma, 14 3 3 protein gamma subtype, 14-3-3 protein gamma, 1433G_HUMAN, 18A2, 3 monooxygenase/tryptophan 5 monooxgenase activation protein gamma polypeptide, 42A, 90 kda heat shock protein beta HSP90 beta, A830040C14Rik, ACLS, AI838772, AIS, ANDR_HUMAN, APOPAIN, AR, AR8, ARO, ARO1, ATAD5_HUMAN, ATPase family AAA domain containing 5, ATPase family AAA domain-containing protein 5, AW493413, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Antigen NY-CO-13, Apoptotic protease Mch-3, Aromatase, Atherosclerosis, susceptibility to, included, Avian erythroblastosis virus E-26 (v-ets) oncogene related, BAR, BCC7, Bile acid receptor, C17orf41, CAPL, CAR, CAR BETA, CARA, CASP3_HUMAN, CASP7_HUMAN, CC3, CMH-1, CP19A_HUMAN, CPP-32, CPP32B, CPV1, CYAR, CYP19, CYPXIX, Calvasculin, Car 1, Casp3a, Caspase 3, apoptosis-related cysteine peptidase, Caspase 3, apoptosis-related cysteine protease, Caspase 3, apoptosis-related cysteine protease a, Caspase 7, Caspase 7 apoptosis related cysteine peptidase, Caspase-3, Caspase-3 subunit p12, Caspase-7 subunit p11, Cellular tumor antigen p53, Chromosome fragility-associated gene 1 protein, Constitutive activator of retinoid response, Constitutive active response, Constitutive androstane receptor, Cyp19a1, Cysteine protease CPP32, Cytochrome P-450AROM, Cytochrome P450 19A1, Cytochrome P450, family 19, subfamily A, polypeptide 1, Cytochrome P450, subfamily XIX (aromatization of androgens), Cytosolic NADP-isocitrate dehydrogenase, D030036I24Rik, D6S182, DHTR, DKFZp686N23123, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 3.4.22.56, ELG1, ER, ER-alpha, ER-beta, ERG/EWS fusion gene, included, ERG/FUS fusion gene, included, ERG/TMPSSR2 fusion gene, included, ERG1, included, ERG2, included, ERG_HUMAN, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, ETS-related gene, Enhanced level of genomic instability 1 homolog, Epididymis luminal protein 216, Epididymis secretory protein Li 26, Era, Erb, Erb2, Erg 3, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen synthase, Estrogen synthetase, Estrogen-related receptor alpha, Estrra, FLJ11090, FLJ26984, FLJ92943, FRAG1, FXR, Farnesoid X receptor, Farnesoid X-activated receptor, Farnesol receptor HRR-1, Fibroblast specific protein, Fibroblast specific protein 1, Fibroblast specific protein 1 (FSP1), GCCR, GCPS, GCRST, GCR_HUMAN, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, GR, Glioma associated oncogene family zinc finger 3, Glucocorticoid receptor, Grl1, HDL cholesterol, augmented response of, to hormone replacement, included, HEL-216, HEL-S-26, HRR 1, HS90A_HUMAN, HS90B_HUMAN, HSP 84, HSP 86, HSP 90, HSP 90 b, HSP90 BETA, HSP90A, HSP90AA1, HSP90AB1, HSPC1, HSPC2, HSPCAL1, HSPCAL4, HSPCB, HUMARA, HYSP1, Heat shock 84 kDa, Heat shock 86 kDa, Heat shock 90kD protein 1, beta, Heat shock 90kDa protein 1 beta, Heat shock protein 90 alpha family class B member 1, Heat shock protein 90 kDa, Heat shock protein 90kDa alpha (cytosolic) class B member 1, Heat shock protein 90kDa alpha cytosolic class A member 1, Heat shock protein 90kDa alpha cytosolic class B member 1, Heat shock protein 90kDa alpha family class B member 1, Heat shock protein HSP 90-alpha, Heat shock protein HSP 90-beta, Heat shock protein beta, ICDH, ICE-LAP3, ICE-like apoptotic protease 3, ICE3, IDCD, IDH, IDH1, IDHC_HUMAN, IDP, IDPC, IMD42, Isocitrate dehydrogenase (NADP(+)) 1 cytosolic, Isocitrate dehydrogenase 1 (NADP+) soluble, Isocitrate dehydrogenase [NADP] cytoplasmic, KD, Kennedy disease (KD), LFS1, LICE, LICE2, Leukemia multidrug resistance associated protein, MB67, MCH3, MGC104252, MGC104309, MGC112732, MGC129539, MGC97144, MTS 1, Malignant transformation suppression 1, Malignant transformation suppression 1 (MTS1), Metastasin, Microsomal monooxygenase, Mutant tumor protein 53, Myocardial infarction, susceptibility to, included, N-terminally processed, NADP dependent isocitrate dehydrogenase cytosolic, NADP dependent isocitrate dehydrogenase peroxisomal, NADP(+)-specific ICDH, NR1B1, NR1F3, NR1H4_HUMAN, NR1I3_HUMAN, NR3A1, NR3A2, NR3B1, NR3C3, NR3C4, Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group B member 1, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group H member 4, Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 3, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form, OTTHUMP00000015467, OTTHUMP00000015468, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000158659, OTTHUMP00000158660, OTTHUMP00000162543, OTTHUMP00000165052, OTTHUMP00000165053, OTTHUMP00000165054, OTTHUMP00000198350, OTTHUMP00000203723, OTTHUMP00000203724, Oncogene ERG, Oncogene GLI3, Orphan nuclear receptor MB67, Orphan nuclear receptor NR1I3, Oxalosuccinate decarboxylase, P 450AROM, P53_HUMAN, P9KA, PAP A, PAPB, PARP cleavage protease, PAX8_HUMAN, PEL98, PGR, PICD, PPD IV, PR, PRA, PRB, PRGR_HUMAN, Paired box 8, Paired box gene 8, Paired box protein Pax-8, Paired domain gene 8, Phosphoprotein p53, Placental calcium-binding protein, Procaspase3, Progesterone receptor, Progestin receptor form A, Progestin receptor form B, Protein Mts1, Protein S100-A4, Protein Yama, Protein kinase C inhibitor protein 1, RAR, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-alpha, RAR-related orphan receptor C, RARA_HUMAN, RARalpha1, RIP 14, RNESTROR, RORG_HUMAN, RP24-311F12.2, RXR-interacting protein 14, RZR GAMMA, RZRG, Renal carcinoma antigen NY-REN-38, Retinoic acid binding receptor gamma, Retinoic acid nuclear receptor alpha variant 1, Retinoic acid nuclear receptor alpha variant 2, Retinoic acid receptor alpha, Retinoic acid receptor alpha polypeptide, Retinoid X receptor-interacting protein 14, Retinoid-related orphan receptor-gamma, Rorc, S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog), S100 calcium-binding protein A4, S10A4_HUMAN, SBMA, SCA-1, SCAN1, SMAX1, SREBP cleavage activity 1, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid hormone receptor ERR1, TFM, TMPRSS2/ERG fusion, TOR, TRP53, TYDP, TYDP1_HUMAN, Testicular Feminization (TFM), Tp53, Transcriptional activator GLI3, Transcriptional regulator ERG, Transcriptional repressor GLI3R, Transformation related protein 53, Transforming protein ERG, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyr-DNA phosphodiesterase 1, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein gamma polypeptide, Tyrosyl-DNA phosphodiesterase 1, V-ets erythroblastosis virus E26 oncogene like (Avian), isoform CRA_e, Yama, Yama protein, Ywhag, Zinc finger protein GLI 3, androgen receptor splice variant 4b, calcium Placental protein, chromosome fragility associated gene 1, constitutive active receptor, constitutive androstane nuclear receptor variant 2, constitutive androstane nuclear receptor variant 3, constitutive androstane nuclear receptor variant 4, constitutive androstane nuclear receptor variant 5, estrogen receptor related receptor alpha, ets related, flavoprotein-linked monooxygenase, glucocorticoid nuclear receptor variant 1, hERR1, mldy, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), orphan nuclear hormone receptor, p53 tumor suppressor, p55, paired box homeotic gene 8, transcriptional regulator ERG (transforming protein ERG), tumor antigen p55, v ets avian erythroblastosis virus E26 oncogene, v ets avian erythroblastosis virus E26 oncogene related, v ets erythroblastosis virus E26 oncogene homolog, v ets erythroblastosis virus E26 oncogene like, v ets erythroblastosis virus E26 oncogene like isoform 2, v-ets erythroblastosis virus E26 oncogene, v-ets erythroblastosis virus E26 oncogene homolog (avian)